by Elizabeth Bibi
SOURCE: Gilead Sciences
DESCRIPTION:
Gilead Sciences, Inc. (Nasdaq: GILD) and the Human Rights Campaign (HRC), the nation’s largest lesbian, gay, bisexual, transgender and queer (LGBTQ+) civil rights organization, announced that Gilead will provide a $3.2 million grant over two years to support communities disproportionately impacted by the HIV epidemic in the United States, particularly communities of color. Gilead will directly fund the efforts of the HRC Foundation – HRC’s educational arm – aimed at ending the HIV epidemic, as well as fund the organization’s Transgender Justice Initiative.
Read the origina and full article on Human Rights Campaign.
KEYWORDS: NYSE:GILD, Gilead Sciences